Skip To Main Content
Anthony Barnett on Muck Rack

Anthony Barnett

As seen in: The Lancet
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anthony

Contact Anthony, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Type 2 diabetes management: weekly combination therapy comes of age?

|
By Hospitals Birmingham, Muhammad Ali Karamat, Anthony Barnett
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Hirsch, IB ∙ Juneja, R ∙ Beals, JM ∙ et al. The evolution of insulin and how it informs therapy and treatment choices Endocr Rev. 2020; 41:733-755 2. Rosenstock, J ∙ Juneja, R ∙ Beals, JM ∙ et al. The basis for weekly insulin therapy: evolving evidence with insulin icodec and insulin efsitora alfa Endocr Rev. 2024; 45:379-413 3. Nauck, MA ∙ Quast, DR ∙ Wefers, J ∙ et al.
Open in Who Shared Issue with article?

Insulin icodec: evolution or revolution in diabetes therapy?

|
By Anthony Barnett
| The Lancet Verified
Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
Open in Who Shared View Duplicates (21) Issue with article?

Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

|
By Srikanth Bellary, Abd A Tahrani, Anthony Barnett
| The Lancet Verified
Kidney disease affects around 40% of people with type 2 diabetes and is a leading cause of morbidity and mortality. Management of diabetic kidney disease has traditionally focused on tight glycaemic control (in the early stages) and blood pressure control (with agents that inhibit the renin–angiotensin system).
Open in Who Shared Issue with article?
See all 7 articles